首頁 > 市場調查報告書 > 製藥

疫苗動物用醫藥

市場調查報告書

商品編碼

2126730

甘保羅症市場：按類型、疫苗類型和地區分類

Gumboro Disease Market, By Species Type (Broilers and Layers), By Vaccine Type (Conventional Vaccines, Antibody/ Antigen Complex Vaccines, and Vectored Vaccines), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: 2026年08月19日 | 出版商:

Coherent Market Insights | 英文 256 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，甘保羅症市場規模將達到 3.389 億美元，到 2033 年將達到 5.846 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 8.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	3.389億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.10%	2033年市場規模預測：	5.846億美元

該市場正經歷穩定成長，主要促進因素包括商業家禽生產的擴張、傳染性法薩爾病（IBD）爆發風險的增加、家禽預防性疫苗接種計劃的推廣以及傳統疫苗、免疫複合物疫苗和重組/載體疫苗使用量的增加。甘保羅症（也稱為傳染性法薩爾氏症 (IBD)）是一種高度傳染性的病毒性疾病，主要影響幼雞，並可導致嚴重的免疫抑制，凸顯了有效疾病預防和疫苗接種計劃日益成長的需求。

該市場涵蓋多種疫苗類型，例如傳統疫苗、抗體-抗原結合疫苗和載體疫苗。傳統疫苗，包括減毒活疫苗和去活化疫苗，在現有的家禽免疫計劃中仍然發揮著重要作用，但由於免疫結合疫苗和重組/載體疫苗適用於孵化場疫苗接種和先進的疾病控制策略，它們的重要性日益凸顯。

商業家禽養殖戶越來越重視疫苗接種、孵化場免疫、疾病監測和毒株監測，以保護肉雞和蛋雞免受不斷演變的傳染性法氏囊病病毒（IBDV）毒株的侵害。重組疫苗和多價家禽疫苗的進步簡化了疫苗接種程序，能夠預防甘保羅症和其他主要家禽疾病，並進一步提高疫苗接種效率。新一代基於DNA和奈米顆粒的疫苗平台的出現也代表著市場上的一項重大技術進步。

市場動態

由於全球商業家禽生產和養殖規模的持續擴張，甘保羅症市場呈現強勁成長動能。集約化肉雞、蛋雞和種雞產量的增加，導致需要定期接種傳染性法氏囊病疫苗的家禽數量上升。商業家禽，尤其是肉雞的高週轉率，使得孵化場和雛雞早期階段的疫苗接種需求持續成長。因此，不斷成長的疫苗接種需求和維護雞群健康的需求，正在推動甘保羅症疫苗的需求。

傳染性法氏囊病病毒（IBDV）持續的基因演化是影響市場發展的另一個主要因素。新型變異株和高致病性株可對鐮狀細胞造成顯著損傷和免疫抑制，而抗原變化則可能降低現有疫苗接種方案的有效性。這凸顯了分子監測、病毒株監測、疫苗更新以及提供更廣泛保護的疫苗接種策略日益成長的重要性。

技術進步也推動了市場擴張。重組疫苗、載體疫苗、免疫複合物疫苗和多價家禽疫苗正日益被納入商業性疫苗接種策略。這些技術提高了孵化場的疫苗接種效率，並有助於更廣泛地預防疾病。同時，對DNA疫苗、脂質奈米顆粒遞送系統和其他新一代疫苗技術的研究，也為更好地抵禦新出現的傳染性法氏囊病病毒（IBDV）變種病毒創造了機會。

此外，監管機構日益重視疫苗品質、生產控制、可追溯性和動物用藥品合規性，也對市場產生了影響。雖然獸用生物製藥和免疫製品生產要求的更新有望提高產品品質和可靠性，但同時也可能導致對生產商的驗證、文件記錄、品管和合規性提出更嚴格的要求。

然而，疫苗研發和生產的高昂成本仍是市場面臨的一大挑戰。此外，新型高致病性傳染性法氏囊病病毒（IBDV）病毒株的出現，也持續迫使疫苗生產商和家禽養殖戶更新其疾病防治和疫苗接種策略。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數分析甘保羅症市場的主要參與者：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使行銷負責人和企業經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
甘保羅症市場報告的目標受群眾外包括該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用甘保羅症市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Ceva
- ROMVAC Company SA
- PTSanbe Farma
- Jiangyin Caina Technology co. limited
- Cios Co.
- Salfarm Danmark A/s.
- Vetbiochem
- Others
分析師意見

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI783

Gumboro Disease Market is estimated to be valued at USD 338.9 Mn in 2026 and is expected to reach USD 584.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 338.9 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.10%	2033 Value Projection:	USD 584.6 Mn

The market is witnessing steady growth primarily driven by expansion of commercial poultry production, increasing risk of Infectious Bursal Disease (IBD) outbreaks, rising adoption of preventive poultry vaccination programs, and wider use of conventional, immune-complex, and recombinant/vector vaccines. Gumboro disease, also known as Infectious Bursal Disease (IBD), is a highly contagious viral disease primarily affecting young chickens and can cause significant immunosuppression, strengthening the need for effective disease-prevention and vaccination programs.

The market includes a range of vaccine approaches such as conventional vaccines, antibody/antigen complex vaccines, and vectored vaccines. Conventional vaccines, including live-attenuated and inactivated vaccines, continue to form an important part of established poultry immunization programs, while immune-complex and recombinant/vector vaccines are gaining importance owing to their suitability for hatchery vaccination and advanced disease-control strategies.

Commercial poultry producers are increasingly focusing on preventive vaccination, hatchery-level immunization, disease surveillance, and strain monitoring to protect broiler and layer populations from evolving IBDV strains. Advances in recombinant and multivalent poultry vaccines are further supporting vaccination efficiency by enabling protection against Gumboro disease alongside other major poultry diseases through simplified vaccination schedules. The emergence of next-generation DNA and nanoparticle-based vaccine platforms also represents an important technological development within the market.

Market Dynamics

The Gumboro Disease Market is witnessing significant momentum owing to the continued expansion of global commercial poultry production and flock sizes. Growth in intensive broiler, layer, and breeder production increases the number of birds requiring routine preventive vaccination against Infectious Bursal Disease. The high turnover of commercial poultry populations, particularly broilers, creates recurring demand for vaccination during hatchery and early-life stages. Increasing preventive vaccination and the need to maintain flock health are therefore strengthening demand for Gumboro disease vaccines.

The continued genetic evolution of Infectious Bursal Disease Virus (IBDV) is another major factor influencing market development. Novel variant and highly virulent strains can result in significant bursal damage and immunosuppression, while antigenic changes may reduce the effectiveness of existing vaccination programs. This is increasing the importance of molecular surveillance, strain monitoring, vaccine updates, and broader-protection vaccination strategies.

Technological developments are also supporting market expansion. Recombinant, vectored, immune-complex, and multivalent poultry vaccines are increasingly being incorporated into commercial vaccination strategies. These technologies can improve hatchery vaccination efficiency and facilitate broader disease protection. At the same time, research into DNA vaccines, lipid nanoparticle delivery systems, and other next-generation vaccine approaches is creating opportunities for improved protection against emerging IBDV variants.

The market is also influenced by increasing regulatory emphasis on vaccine quality, manufacturing controls, traceability, and veterinary medicinal product compliance. Updated manufacturing requirements for veterinary biological and immunological medicines are expected to strengthen product quality and confidence, although manufacturers may face higher validation, documentation, quality-control, and compliance requirements.

However, high vaccine development and manufacturing costs remain an important market challenge. In addition, the emergence of new and highly virulent IBDV strains creates continuous pressure on vaccine manufacturers and poultry producers to update disease-management and vaccination strategies.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Gumboro Disease Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Ceva, ROMVAC Company SA, PTSanbe Farma, Jiangyin Caina Technology co. limited, Cios Co., Salfarm Danmark A/s., Vetbiochem, and others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Gumboro Disease Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Gumboro Disease Market

Market Segmentation

By Species Type (Revenue, USD Mn, 2026-2033)
Broilers
Layers
By Vaccine Type (Revenue, USD Mn, 2026-2033)
Conventional Vaccines
Antibody/ Antigen Complex Vaccines
Vectored Vaccines
Global Gumboro Disease Market, By Region (Revenue, USD Mn, 2026-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Ceva
ROMVAC Company SA
PTSanbe Farma
Jiangyin Caina Technology co. limited
Cios Co.
Salfarm Danmark A/s.
Vetbiochem
Others

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Species Type
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Gumboro Disease Market, By Species Type, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Broilers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Layers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

5. Global Gumboro Disease Market, By Vaccine Type, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Conventional Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Antibody/ Antigen Complex Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Vectored Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

6. Global Gumboro Disease Market, By Region, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Species Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Species Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Species Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Species Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Species Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Species Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Ceva
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- ROMVAC Company SA
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- PTSanbe Farma
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Jiangyin Caina Technology co. limited
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cios Co.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Salfarm Danmark A/s.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Vetbiochem
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Others
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views